Interest Paid, Excluding Capitalized Interest, Operating Activities in USD of Propanc Biopharma, Inc. from 2017 to Q3 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
-
Summary
-
Propanc Biopharma, Inc. quarterly/annual Interest Paid, Excluding Capitalized Interest, Operating Activities history and change rate from 2017 to Q3 2025.
- Propanc Biopharma, Inc. Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending 30 Sep 2025 was $116K, a 4339% increase year-over-year.
- Propanc Biopharma, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2025 was $30.7K, a 224% increase from 2024.
- Propanc Biopharma, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2024 was $9.49K, a 229% increase from 2023.
- Propanc Biopharma, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2023 was $2.88K, a 20.5% increase from 2022.
Interest Paid, Excluding Capitalized Interest, Operating Activities, Quarterly (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Quarterly Change (%)
Interest Paid, Excluding Capitalized Interest, Operating Activities, Annual (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Annual Change (%)